Clinical Cancer Research Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biemer-Hüttmann, A.-E.
Right arrow Articles by Jass, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biemer-Hüttmann, A.-E.
Right arrow Articles by Jass, J. R.
Clinical Cancer Research Vol. 6, 1909-1916, May 2000
© 2000 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Mucin Core Protein Expression in Colorectal Cancers with High Levels of Microsatellite Instability Indicates a Novel Pathway of Morphogenesis1

Anne-Eve Biemer-Hüttmann, Michael D. Walsh, Michael A. McGuckin, Lisa A. Simms, Joanne Young, Barbara A. Leggett and Jeremy R. Jass2

Department of Pathology, Mayne Medical School, University of Queensland, Herston, Queensland 4006, Australia [A-E. B-H., M. D. W., J. R. J.]; Mater Medical Research Institute, Mater Misericordiae Hospital, South Brisbane, Queensland 4101, Australia [M. A. M.]; and Conjoint Gastroenterology Laboratory, Royal Brisbane Hospital, Herston QLD 4029, Australia [L. A. S., J. Y., B. A. L.]

Particular mucinous phenotypes have been associated with serrated epithelial polyps of the colon. These polyps also show a high frequency of DNA instability. The aim of this study was to examine the expression of mucins in colorectal cancers that arise through the suppressor and mutator pathways. The immunohistochemical distribution of the human apomucins MUC1, MUC2, MUC4, and MUC5AC was determined in 93 sporadic colorectal cancers classified previously (J. R. Jass et al., J. Clin. Pathol., 52: 455–460, 1999) according to levels of DNA microsatellite instability (MSI) as 22 MSI-high (MSI-H), 24 MSI-low (MSI-L), and 47 MS stable (MSS). MUC2 expression was observed in 19 (86%) MSI-H, 10 (42%) MSI-L, and 15 (32%) MSS cancers (P = 0.0001); and MUC5AC expression was observed in 17 (77%) MSI-H, 8 (33%) MSI-L, and 13 (28%) MSS cancers (P = 0.0003). There was no association between MUC1 or MUC4 expression and MSI status. The mucinous phenotype described in serrated polyps (MUC2+/MUC5AC+) was seen in 15 (68%) of 22 MSI-H and only 10 (14%) of 71 MSI-L/MSS cancers (P < 0.0001). Increased expression of the secretory mucins MUC2 and MUC5AC was observed in sporadic MSI-H cancers. Identical mucin changes and DNA MSI occurred in serrated polyps of the colorectum, which suggests that these lesions may represent precursors of MSI-H cancers.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
A S Mall
Analysis of mucins: role in laboratory diagnosis
J. Clin. Pathol., September 1, 2008; 61(9): 1018 - 1024.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. R. English, J. P. Young, J. A. Simpson, M. A. Jenkins, M. C. Southey, M. D. Walsh, D. D. Buchanan, M. A. Barker, A. M. Haydon, S. G. Royce, et al.
Ethnicity and Risk for Colorectal Cancers Showing Somatic BRAF V600E Mutation or CpG Island Methylator Phenotype
Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1774 - 1780.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A Lugli, I Zlobec, K Baker, P Minoo, L Tornillo, L Terracciano, and J R Jass
Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status
J. Clin. Pathol., May 1, 2007; 60(5): 534 - 539.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
P Minoo, K Baker, R Goswami, G Chong, W D Foulkes, A R Ruszkiewicz, M Barker, D Buchanan, J Young, and J R Jass
Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis
Gut, October 1, 2006; 55(10): 1467 - 1474.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J.-F. You, L.-L. Hsieh, C. R. Changchien, J.-S. Chen, J.-R. Chen, J.-M. Chiang, C. Y. Yeh, P.-S. Hsieh, C.-W. Fan, C.-T. Liu, et al.
Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients.
Clin. Cancer Res., July 15, 2006; 12(14): 4244 - 4250.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
K Baker, Y Zhang, C Jin, and J R Jass
Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum?
J. Clin. Pathol., October 1, 2004; 57(10): 1089 - 1093.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
T Higuchi and J R Jass
My approach to serrated polyps of the colorectum
J. Clin. Pathol., July 1, 2004; 57(7): 682 - 686.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. G. Kohlgraf, A. J. Gawron, M. Higashi, J. L. Meza, M. D. Burdick, S. Kitajima, D. L. Kelly, T. C. Caffrey, and M. A. Hollingsworth
Contribution of the MUC1 Tandem Repeat and Cytoplasmic Tail to Invasive and Metastatic Properties of a Pancreatic Cancer Cell Line
Cancer Res., August 15, 2003; 63(16): 5011 - 5020.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Mori, F. M. Selaru, F. Sato, J. Yin, L. A. Simms, Y. Xu, A. Olaru, E. Deacu, S. Wang, J. M. Taylor, et al.
The Impact of Microsatellite Instability on the Molecular Phenotype of Colorectal Tumors
Cancer Res., August 1, 2003; 63(15): 4577 - 4582.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. L. J. Whitehall, C. V. A. Wynter, M. D. Walsh, L. A. Simms, D. Purdie, N. Pandeya, J. Young, S. J. Meltzer, B. A. Leggett, and J. R. Jass
Morphological and Molecular Heterogeneity within Nonmicrosatellite Instability-High Colorectal Cancer
Cancer Res., November 1, 2002; 62(21): 6011 - 6014.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Young, L. A. Simms, K. G. Biden, C. Wynter, V. Whitehall, R. Karamatic, J. George, J. Goldblatt, I. Walpole, S.-A. Robin, et al.
Features of Colorectal Cancers with High-Level Microsatellite Instability Occurring in Familial and Sporadic Settings : Parallel Pathways of Tumorigenesis
Am. J. Pathol., December 1, 2001; 159(6): 2107 - 2116.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. David, F. Silva, R. Seruca, M. Pinto, C. Reis, and M. Sobrinho-Simoes
Correspondence re: A. E. Biemer-Huttmann et al., Mucin Core Protein Expression in Colorectal Cancers with High Levels of Microsatellite Instability Indicates a Novel Pathway of Morphogenesis. Clin. Cancer Res., 6: 1909-1916, 2000.
Clin. Cancer Res., November 1, 2000; 6(11): 4461 - 4462.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.